Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The black box of the relationship between breast cancer patients and accompanying patients: the accompanied patients' point of view.
Pomey MP, Iliescu Nelea M, Vialaron C, Normandin L, Côté MA, Desforges M, Pomey-Carpentier P, Adjtoutah N, Fortin I, Ganache I, Régis C, Rosberger Z, Charpentier D, Bélanger L, Dorval M, Ghadiri DP, Lavoie-Tremblay M, Boivin A, Pelletier JF, Fernandez N, Danino AM, de Guise M. Pomey MP, et al. Among authors: fortin i. BMC Cancer. 2024 Jul 10;24(1):822. doi: 10.1186/s12885-024-12585-z. BMC Cancer. 2024. PMID: 38987731 Free PMC article.
Accompanying patients in clinical oncology teams: Reported activities and perceived effects.
Pomey MP, Paquette J, Iliescu-Nelea M, Vialaron C, Mourad R, Bouchard K, Normandin L, Côté MA, Desforges M, Pomey-Carpentier P, Fortin I, Ganache I, Régis C, Rosberger Z, Charpentier D, Bélanger L, Dorval M, Ghadiri DP, Lavoie-Tremblay M, Boivin A, Pelletier JF, Fernandez N, Danino AM, de Guise M. Pomey MP, et al. Among authors: fortin i. Health Expect. 2023 Apr;26(2):847-857. doi: 10.1111/hex.13710. Epub 2023 Jan 26. Health Expect. 2023. PMID: 36704843 Free PMC article.
An exploratory cross-sectional study of the effects of ongoing relationships with accompanying patients on cancer care experience, self-efficacy, and psychological distress.
Pomey MP, Nelea MI, Normandin L, Vialaron C, Bouchard K, Côté MA, Duarte MAR, Ghadiri DP, Fortin I, Charpentier D, Lavoie-Tremblay M, Fernandez N, Boivin A, Dorval M, Desforges M, Régis C, Ganache I, Bélanger L, Rosberger Z, Danino MA, Pelletier JF, Vu TTT, de Guise M. Pomey MP, et al. Among authors: fortin i. BMC Cancer. 2023 Apr 22;23(1):369. doi: 10.1186/s12885-023-10856-9. BMC Cancer. 2023. PMID: 37087438 Free PMC article.
Integrating accompanying patients into clinical oncology teams: limiting and facilitating factors.
Pomey MP, Paquette J, Nelea MI, Vialaron C, Mourad R, Bouchard K, Normandin L, Côté MA, Desforges M, Pomey-Carpentier P, Fortin I, Ganache I, Régis C, Rosberger Z, Charpentier D, Vachon MF, Bélanger L, Dorval M, Ghadiri DP, Lavoie-Tremblay M, Boivin A, Pelletier JF, Fernandez N, Danino AM, de Guise M. Pomey MP, et al. Among authors: fortin i. BMC Health Serv Res. 2024 Jan 30;24(1):150. doi: 10.1186/s12913-024-10624-w. BMC Health Serv Res. 2024. PMID: 38291443 Free PMC article.
Tofacitinib Safety and Effectiveness in Canadian Patients with Rheumatoid Arthritis by Cardiovascular Risk Enrichment: Subanalysis of the CANTORAL Study.
Haraoui B, Khraishi M, Choquette D, Fortin I, Kinch CD, Galos C, Roy P, Gruben D, Vaillancourt J, Sampalis JS, Keystone EC. Haraoui B, et al. Among authors: fortin i. Rheumatol Ther. 2024 Dec;11(6):1629-1648. doi: 10.1007/s40744-024-00719-5. Epub 2024 Nov 1. Rheumatol Ther. 2024. PMID: 39485671 Free PMC article.
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study.
Fisher BA, Mariette X, Papas A, Grader-Beck T, Bootsma H, Ng WF, van Daele PLA, Finzel S, Noaiseh G, Elgueta S, Hermann J, McCoy SS, Akpek E, Bookman A, Sopala M, Montecchi-Palmer M, Luo WL, Scheurer C, Hueber W; TWINSS study group. Fisher BA, et al. Lancet. 2024 Aug 10;404(10452):540-553. doi: 10.1016/S0140-6736(24)01211-X. Epub 2024 Jul 31. Lancet. 2024. PMID: 39096929 Clinical Trial.
Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper.
Spiera RF, Unizony S, Warrington KJ, Sloane J, Giannelou A, Nivens MC, Akinlade B, Wong W, Bhore R, Lin Y, Buttgereit F, Devauchelle-Pensec V, Rubbert-Roth A, Yancopoulos GD, Marrache F, Patel N, Dasgupta B; SAPHYR Investigators. Spiera RF, et al. N Engl J Med. 2023 Oct 5;389(14):1263-1272. doi: 10.1056/NEJMoa2303452. N Engl J Med. 2023. PMID: 37792612 Clinical Trial.
Measuring the impact of an educational intervention in rheumatoid arthritis: An open-label, randomized trial.
Michou L, Julien AS, Witteman HO, Légaré J, Ratelle L, Godbout A, Tardif J, Côté S, Boily G, Lui R, Ikic A, Trudeau J, Tremblay JL, Fortin I, Bessette L, Chetaille AL, Fortin PR. Michou L, et al. Among authors: fortin i. Arch Rheumatol. 2021 Dec 24;37(2):169-179. doi: 10.46497/ArchRheumatol.2022.8965. eCollection 2022 Jun. Arch Rheumatol. 2021. PMID: 36017212 Free PMC article.
Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study.
Haraoui B, Khraishi M, Choquette D, Lisnevskaia L, Teo M, Kinch C, Galos C, Roy P, Gruben D, Woolcott JC, Vaillancourt J, Sampalis JS, Keystone EC; Canadian Tofacitinib for Rheumatoid Arthritis Observational Investigators. Haraoui B, et al. Arthritis Care Res (Hoboken). 2023 Feb;75(2):240-251. doi: 10.1002/acr.24966. Epub 2022 Oct 10. Arthritis Care Res (Hoboken). 2023. PMID: 35678771 Free PMC article.
37 results